InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
14
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hernandez Marlow, PDG. Officer active across 1 company, notably Cano Health, Inc.. Cumulatively, 26 disclosures have been published. Split: 14 buys · 0 sell. Total volume traded: €4m. History available since 16 August 2021. The latest transaction was disclosed on 3 January 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations26 total
189,681 sharesClass A Common StockSEC:0001209191-23-042327:0
671,742 sharesClass A Common StockSEC:0000950170-23-026059:0
348,604 sharesClass A Common StockSEC:0000899243-23-010565:0
134,660 shares@ US$0.8671.7% of flowClass A Common StockSEC:0000899243-23-000963:0
11,017,311 shares0Class A Common StockSEC:0000899243-22-039535:0
29,870 shares@ US$3.521.6% of flowClass A Common StockSEC:0000899243-22-025682:0
11,017,311 shares0Class A Common StockSEC:0000899243-22-020172:0
624,418 sharesClass A Common StockSEC:0000899243-22-011466:0
15,000 shares@ US$8.001.7% of flowClass A Common StockSEC:0000899243-21-047185:0
Ideal exit: 2 Sept 2022 (T+270)
15,000 shares@ US$8.001.7% of flowClass A Common StockSEC:0000899243-21-047185
Ideal exit: 2 Sept 2022 (T+270)
12,500 shares@ US$8.751.6% of flowClass A Common StockSEC:0000899243-21-046941:0
Ideal exit: 30 Aug 2022 (T+270)
12,500 shares@ US$8.751.5% of flowClass A Common StockSEC:0000899243-21-046941
Ideal exit: 30 Aug 2022 (T+270)
8,000 shares@ US$9.651.1% of flowClass A Common StockSEC:0000899243-21-046067:0
Ideal exit: 19 Aug 2022 (T+270)
8,000 shares@ US$9.651.1% of flowClass A Common StockSEC:0000899243-21-046067
Ideal exit: 19 Aug 2022 (T+270)
1,339,500 sharesClass A Common StockSEC:0000899243-21-037547:0
1,339,500 sharesClass A Common StockSEC:0000899243-21-037547
5,833 shares@ US$11.991.0% of flowClass A Common StockSEC:0000899243-21-034907:0
Ideal exit: 28 May 2022 (T+270)
5,833 shares@ US$11.990.9% of flowClass A Common StockSEC:0000899243-21-034907
Ideal exit: 28 May 2022 (T+270)
54,727 shares@ US$11.938.8% of flowClass A Common StockSEC:0000899243-21-034612
Ideal exit: 22 May 2022 (T+270)
54,727 shares@ US$11.939.1% of flowClass A Common StockSEC:0000899243-21-034612:0
Ideal exit: 22 May 2022 (T+270)
120,000 shares@ US$10.1616.9% of flowClass A Common StockSEC:0000899243-21-033876:0
Ideal exit: 13 May 2022 (T+270)
11,900 shares@ US$9.821.6% of flowClass A Common StockSEC:0000899243-21-033963:0
Ideal exit: 15 May 2022 (T+270)
11,900 shares@ US$9.821.6% of flowClass A Common StockSEC:0000899243-21-033963
Ideal exit: 15 May 2022 (T+270)
120,000 shares@ US$10.1616.4% of flowClass A Common StockSEC:0000899243-21-033876
Ideal exit: 13 May 2022 (T+270)
120,000 shares@ US$10.1616.9% of flowClass A Common StockSEC:0000899243-21-033441:0
25 of 26 declarations
About Hernandez Marlow
Hernandez Marlow is an executive at Cano Health, Inc.
